+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dynavax Technologies Corporation - logo

Dynavax is a clinical-stage biopharmaceutical company with multiple product candidates in development for the treatment of autoimmune and inflammatory diseases, and the treatment of cancer. The company’s lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine; and AZD1419, which is in Phase II clinical trial for the treatment of asthma. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.

From
From
From
2021 Clinical Trial Analytics of the Microbiome Landscape - Product Thumbnail Image

2021 Clinical Trial Analytics of the Microbiome Landscape

  • Report
  • April 2021
  • 9 Pages
  • Global
From
Travel Vaccines Global Market Report 2024 - Product Thumbnail Image

Travel Vaccines Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
H1N1 Vaccine Global Market Report 2024 - Product Thumbnail Image

H1N1 Vaccine Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Vaccine Adjuvants Global Market Report 2024 - Product Thumbnail Image

Vaccine Adjuvants Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Conjugate Vaccine Global Market Report 2024 - Product Thumbnail Image

Conjugate Vaccine Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Adult Vaccines Global Market Report 2024 - Product Thumbnail Image

Adult Vaccines Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
DNA Vaccines Market - Forecast (2022 - 2027) - Product Thumbnail Image

DNA Vaccines Market - Forecast (2022 - 2027)

  • Report
  • January 2022
  • 121 Pages
  • Global
From
Hepatitis B - Pipeline Review, H2 2020 - Product Thumbnail Image

Hepatitis B - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 575 Pages
  • Global
From
Coronavirus (COVID-19) Vaccine Pipeline Assessment 2020 - Product Thumbnail Image

Coronavirus (COVID-19) Vaccine Pipeline Assessment 2020

  • Report
  • April 2020
  • 135 Pages
  • Global
From
Pertussis - Pipeline Insight, 2024 - Product Thumbnail Image

Pertussis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 70 Pages
  • Global
From
Rheumatoid Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1191 Pages
  • Global
From
From
Loading Indicator